Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigeru Kosuda

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Clinical Imaging|September 13, 2005
Castleman's disease arising from the accessory spleen: ultrasonography, computed tomography, and magnetic resonance imaging findingsChiharu Sakaguchi, Yukihiro Hama, Yoshiko Kadota, et al.
Clinical Nuclear Medicine|April 9, 2009
Intense accumulation of Tc-99m MDP in pericardial metastasis from breast cancerTakatsugu Kawase, Hirofumi Fujii, Tadaki Nakahara, et al.
Heart Rhythm|March 29, 2006
QT peak dispersion, not QT dispersion, is a more useful diagnostic marker for detecting exercise-induced myocardial ischemiaNobuyuki Masaki, Bonpei Takase, Takemi Matsui, et al.
Japanese Journal of Radiology|April 27, 2013
Pseudomesotheliomatous lung cancer mimicking mesothelioma on ¹⁸F-FDG PET/CT images: report of 2 casesTakatoshi Nakamori, Shigeru Kosuda, Yukishige Kyoto, et al.
Annals of Nuclear Medicine|March 6, 2010
Questionnaire survey of hospitals in Saitama Prefecture regarding the shortage of 99mTc-labeled radiopharmaceuticals and 99Mo/99mTc generatorsShigeru Kosuda, Hiroko Tomita, Katsumi Hayashi, et al.
Nihon Jibiinkoka Gakkai Kaiho|June 25, 2014
[Impact of 131I SPECT/CT on the management of differentiated thyroid carcinoma outpatients with radioablation]Daisuke Mizokami, Shigeru Kosuda, Akihiro Shiotani, et al.
Annals of Nuclear Medicine|October 25, 2003
Does supplementation of CT and MRI with gallium-67 SPECT improve the differentiation between benign and malignant tumors of the head and neck?Shigeru Kosuda, Yoshiko Kadota, Satoshi Umeda, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|February 5, 2005
[Changes in national insurance reimbursement with introduction of the DPC package payment system for 131I therapy for hyperthyroidism]Sadahiro Watanabe, Shigeru Kosuda, Fuzuki Yano, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|July 26, 2005
[Cost-utility analysis of antithyroid drug therapy versus 131I therapy for Graves' disease]Katsumi Hayashi, Katsumi Abe, Ikuko Sakata, et al.
Annals of Nuclear Medicine|September 17, 2005
Should mediastinoscopy actually be incorporated into the FDG PET strategy for patients with non-small cell lung carcinoma?Katsumi Hayashi, Katsumi Abe, Fuzuki Yano, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Clinical Imaging|September 13, 2005
Castleman's disease arising from the accessory spleen: ultrasonography, computed tomography, and magnetic resonance imaging findingsChiharu Sakaguchi, Yukihiro Hama, Yoshiko Kadota, et al.
Clinical Nuclear Medicine|April 9, 2009
Intense accumulation of Tc-99m MDP in pericardial metastasis from breast cancerTakatsugu Kawase, Hirofumi Fujii, Tadaki Nakahara, et al.
Heart Rhythm|March 29, 2006
QT peak dispersion, not QT dispersion, is a more useful diagnostic marker for detecting exercise-induced myocardial ischemiaNobuyuki Masaki, Bonpei Takase, Takemi Matsui, et al.
Japanese Journal of Radiology|April 27, 2013
Pseudomesotheliomatous lung cancer mimicking mesothelioma on ¹⁸F-FDG PET/CT images: report of 2 casesTakatoshi Nakamori, Shigeru Kosuda, Yukishige Kyoto, et al.
Annals of Nuclear Medicine|March 6, 2010
Questionnaire survey of hospitals in Saitama Prefecture regarding the shortage of 99mTc-labeled radiopharmaceuticals and 99Mo/99mTc generatorsShigeru Kosuda, Hiroko Tomita, Katsumi Hayashi, et al.
Nihon Jibiinkoka Gakkai Kaiho|June 25, 2014
[Impact of 131I SPECT/CT on the management of differentiated thyroid carcinoma outpatients with radioablation]Daisuke Mizokami, Shigeru Kosuda, Akihiro Shiotani, et al.
Annals of Nuclear Medicine|October 25, 2003
Does supplementation of CT and MRI with gallium-67 SPECT improve the differentiation between benign and malignant tumors of the head and neck?Shigeru Kosuda, Yoshiko Kadota, Satoshi Umeda, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|February 5, 2005
[Changes in national insurance reimbursement with introduction of the DPC package payment system for 131I therapy for hyperthyroidism]Sadahiro Watanabe, Shigeru Kosuda, Fuzuki Yano, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|July 26, 2005
[Cost-utility analysis of antithyroid drug therapy versus 131I therapy for Graves' disease]Katsumi Hayashi, Katsumi Abe, Ikuko Sakata, et al.
Annals of Nuclear Medicine|September 17, 2005
Should mediastinoscopy actually be incorporated into the FDG PET strategy for patients with non-small cell lung carcinoma?Katsumi Hayashi, Katsumi Abe, Fuzuki Yano, et al.
Pageof 6